Transforming growth factor-beta inhibition attenuates pulmonary arterial hypertension in rats
| dc.contributor.author | Megalou, A. J. | en |
| dc.contributor.author | Glava, C. | en |
| dc.contributor.author | Oikonomidis, D. L. | en |
| dc.contributor.author | Vilaeti, A. | en |
| dc.contributor.author | Agelaki, M. G. | en |
| dc.contributor.author | Baltogiannis, G. G. | en |
| dc.contributor.author | Papalois, A. | en |
| dc.contributor.author | Vlahos, A. P. | en |
| dc.contributor.author | Kolettis, T. M. | en |
| dc.date.accessioned | 2015-11-24T19:11:20Z | |
| dc.date.available | 2015-11-24T19:11:20Z | |
| dc.identifier.issn | 1940-5901 | - |
| dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/20920 | |
| dc.rights | Default Licence | - |
| dc.title | Transforming growth factor-beta inhibition attenuates pulmonary arterial hypertension in rats | en |
| heal.abstract | The role of transforming growth factor-beta in the pathogenesis of pulmonary arterial hypertension is unclear. We examined the effects of T9429, an antibody against transforming growth factor-beta receptors, on hemodynamic, histological and functional parameters in the rat model of monocrotaline-induced pulmonary hypertension. One week after monocrotaline injection (60 mg/kg) in 28 Wistar rats, T9429 (0.1mg/kg daily) was administered intraperito-neally in 19 rats (268+/-10g) via an osmotic mini-pump for 7 days. One week thereafter, right ventricular systolic pressure, pulmonary vascular remodeling and exercise tolerance were evaluated. Compared to the monocrotaline group (25.5+/-1.9mmHg), right ventricular systolic pressure was lower (p=0.0014) in the monocrotaline+antibody group (18.4+/-0.8mmHg). This was translated into attenuated right ventricular hypertrophy (p=0.0063) and longer (p=0.0155) exercise duration (2.08+/-0.29min versus 6.19+/-1.02min). Pulmonary arterial wall thickness (in vessels 50 -200mum) was comparable between the two groups, but the monocrotaline+antibody group displayed lower number (p<0.0001) of pre-capillary arterioles (<50mum, in 20 randomly selected fields) with a muscularized media (23.33+/-3.15 versus 6.64+/-0.75). Our results suggest that transforming growth factor-beta receptor blockade improves vascular remodeling and attenuates pulmonary hypertension, a finding with potential therapeutic implications. | en |
| heal.access | campus | - |
| heal.fullTextAvailability | TRUE | - |
| heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/21072267 | - |
| heal.journalName | Int J Clin Exp Med | en |
| heal.journalType | peer-reviewed | - |
| heal.language | en | - |
| heal.publicationDate | 2010 | - |
| heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
| heal.type | journalArticle | - |
| heal.type.el | Άρθρο Περιοδικού | el |
| heal.type.en | Journal article | en |
Αρχεία
Φάκελος/Πακέτο αδειών
1 - 1 of 1
Φόρτωση...
- Ονομα:
- license.txt
- Μέγεθος:
- 1.74 KB
- Μορφότυπο:
- Item-specific license agreed upon to submission
- Περιγραφή: